*** SHOW NOTES [ 00:00 ] Introduction [ 03:00 ] The Big Claim: "GLP-1s Will Change Medicine Forever" [ 06:00 ] Inflammation: The Root Cause GLP-1s Quiet [ 09:00 ] Why Thyroid Patients Are Seeing Breakthrough Results [ 12:00 ] The 1014% Lower Mortality Statistic [ 15:00 ] The Danger of Standardized Dosing [ 18:00 ] Red Flags That a Dose Is Too High [ 21:00 ] Ozempic Face, Muscle Loss & Hair Loss What's Really Going On [ 24:00 ] How to Protect Hair, Skin & Muscle While on GLP-1s [ 27:00 ] Why Overprescribing Happens [ 30:00 ] Can You Come Off GLP-1s Successfully
Oral GLP-1 therapy is used to manage type 2 diabetes and support weight loss by regulating blood sugar and appetite
SGLT2 Inhibitors SGLT2 is located in the proximal tubule of the kidney and is responsible for about 80% to 90% of blood-glucose reabsorption
Wound healing models incorporating KPV documented effects on inflammation markers, angiogenesis parameters, and collagen deposition, with studies conducted in both healthy and diabetic animal models
For instance, it resulted in greater weight loss than liraglutide (another GLP-1 receptor agonist) and has been associated with weight loss levels comparable to those achieved through bariatric surgery
Regulatory exclusivity periods include five-year new chemical entity (NCE) exclusivity for first-in-class small molecules, three-year clinical investigation exclusivity for new formulations, seven-year orphan drug exclusivity for treatments targeting rare diseases, and six months of pediatric exclusivity attached to existing patents when sponsors conduct FDA-requested pediatric studies [3]